BMI1 and breast carcinoma: It has been reported that PTC-209 at a similar concentration used in our study was able to decrease Bmi-1 protein expression in both MDA-MB-231 and MCF-7 breast cancer cells (Dimri et al., 2016) and A549 lung cancer cells (Yong et al., 2016).